In the US, a peptide body butter is classified as a cosmetic (not a drug) as long as it doesn't claim to treat, cure, prevent, or mitigate disease or alter skin structure or function beyond moisturizing. This means FDA pre-approval is not required, but you must comply with labeling rules, ingredient restrictions, and honest marketing language. In the EU, peptide body butters are cosmetics under Regulation 1223/2009 but face stricter ingredient restrictions (some peptide sources may be prohibited) and mandatory product information file (PIF) submission before market launch. The gap between US and EU regulatory burden is significant: a US body butter can launch in weeks, while an EU product may require 8–12 weeks of documentation and safety data assembly.
US Regulatory Framework: The FDA's regulations for cosmetics are spread across Title 21 CFR (Code of Federal Regulations). A body butter must have a complete and accurate ingredient label (21 CFR 701.3) listing all ingredients in descending order by weight using INCI (International Nomenclature of Cosmetic Ingredients) names. For a peptide body butter, collagen peptides are listed as 'Hydrolyzed Collagen,' silk peptides as 'Sericin' or 'Hydrolyzed Silk,' and elastin as 'Hydrolyzed Elastin.' Trade names for proprietary peptide blends (e.g., 'Matrixyl 3000') are not allowed on the label; you must use the INCI name. Collagen peptides are not on the FDA's prohibited ingredient list (Title 21 CFR 700), nor are most common silk or elastin peptides, so they're legal to use. However, some peptide actives (especially synthetic ones or novel sources) may lack safety history; if your formulator sources an obscure peptide, request a safety assessment or Cosmetic Ingredient Review (CIR) certificate.
Claim restrictions are the biggest compliance risk. In the US, a body butter can claim: 'Moisturizes,' 'Hydrates,' 'Softens skin,' 'Improves appearance of fine lines,' 'Smooths texture,' and 'Reduces dryness.' These are classic cosmetic claims supported by simple use testing and consumer perception. Claims like 'Increases collagen production,' 'Boosts skin elasticity,' 'Repairs skin barrier,' or 'Stimulates skin renewal' are borderline and invite FDA scrutiny because they suggest the product alters skin structure or function beyond hydration, which is drug language. If a peptide body butter claims it 'promotes collagen synthesis' or 'triggers fibroblast activity,' the FDA may classify it as a drug and demand clinical evidence. A safer approach: say 'Contains collagen peptides to hydrate and soften skin' rather than 'Stimulates your body to make collagen.' The manufacturer you choose (via AJ Cosmo Labs or independently) should coach you on compliant claim language during product development.
Additional US Compliance: Cosmetics must be manufactured under GMP (though not mandatory certification), but the FDA expects documented quality controls. For a peptide body butter, this means batch records showing ingredient sourcing, microbial testing results, stability data, and customer complaints (if any). You don't file these with the FDA upfront, but if the FDA inspects your facility or your manufacturer's facility, they'll review these records. If your peptide body butter causes adverse effects (rash, irritation, infection), you must report it to the FDA's Adverse Event Reporting System (AERS) within 15 days. Fragrance and color additives used in your body butter must be on the FDA's approved list (21 CFR 700)—most common fragrances are approved, but synthetic dyes or rare plant extracts may not be. Your co-packer should screen ingredients for FDA compliance; if they don't, ask for an ingredient attestation statement confirming all actives are FDA-compliant.
EU Regulatory Framework: The EU treats cosmetics more strictly. A peptide body butter must file a Product Information File (PIF) with the responsible person (usually your co-packer or an EU distributor) and notify the CPNP (Cosmetic Products Notification Portal) before legal sale. The PIF includes: (1) Safety assessment by a qualified person (toxicologist or chemist), (2) Stability data (minimum 3-month room temperature, ideally 12-month), (3) Microbiological testing, (4) COAs for all raw materials, (5) Toxicological data sheets, and (6) Proof of product identity and composition. This process typically takes 4–8 weeks and costs €800–€2,000 depending on formulation complexity. If your peptide body butter contains novel peptides (not previously used in EU cosmetics), you may need additional safety data from the CIR (Cosmetic Ingredient Review) panel or a dedicated safety dossier.
EU Prohibited and Restricted Ingredients: The EU maintains a list of prohibited substances (Annex II of Regulation 1223/2009) and restricted substances (Annex III and IV). Most collagen peptides are allowed, but some marine collagen derived from endangered species is prohibited. Silk peptides are allowed. Some synthetic peptides or peptides with heavy metal contamination risk may be restricted or require additional purity data. Fragrance ingredients used in your body butter are heavily restricted: oakmoss, certain musks, and natural fragrance extracts that were allowed in the US are banned in the EU. This means you may need a different fragrance profile for EU sales than for US sales. Always request an EU Compliance Certificate from your co-packer or ingredient supplier confirming that peptides and other actives meet REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) requirements.
Claim Restrictions in the EU: The EU is more stringent on cosmetic claims. Claims like 'Reduces wrinkles' or 'Anti-aging' are allowed if supported by adequate substantiation (typically in-vivo testing on at least 20 subjects with before-and-after photos). Claims like 'Increases collagen production' or 'Rebuilds skin structure' are drug claims and illegal in cosmetics. The EU's Scientific Committee on Consumer Safety (SCCS) publishes opinion papers on substantiation requirements; if your brand makes peptide-based claims, check SCCS opinions on substantiation standards. Many EU brands are conservative and avoid efficacy claims entirely, sticking to 'Moisturizes with hydrolyzed collagen' or 'Contains peptides for soft, supple skin.'
Global Compliance: If you're launching in both US and EU, formulate for EU standards and you'll automatically be compliant in the US (EU standards are stricter). But note: UK post-Brexit has its own cosmetic regulations (similar to EU but with separate notification requirements). Canada requires a Cosmetic Licence and notification via Health Canada. Australia requires TGA (Therapeutic Goods Administration) approval if you make drug-like claims; otherwise, cosmetics are less regulated. Japan has a separate approval system for cosmetics and quasi-drugs. If you plan global distribution, work with a co-packer experienced in multi-region compliance; many on AJ Cosmo Labs have this expertise and can guide you on claim language and documentation for each market.
Manufacturer's Role: Your co-packer is responsible for ensuring ingredients are FDA/EU compliant and often assists with PIF assembly and notification. Confirm in your contract: 'Manufacturer will provide safety data, stability data, and COAs for all ingredients' and 'Manufacturer will support PIF filing if product is sold in the EU.' Some co-packers charge an additional €500–€1,000 for PIF support; some include it in their base quote. Do not launch a product in the EU without filing a PIF; selling without notification can result in product seizure and fines up to €10,000+.
Common Mistakes: (1) Making drug claims ('Increases collagen synthesis') without clinical data and facing FDA warning letters. (2) Sourcing peptides without COAs and later discovering they don't meet REACH standards, requiring expensive reformulation for EU sales. (3) Assuming US compliance means EU compliance—it doesn't. (4) Skipping stability testing and facing product degradation complaints 6 months after launch. (5) Notifying the EU without assembling a complete PIF, leading to rejection and re-notification delays. (6) Using a fragrance approved in the US that's banned in the EU, requiring a reformulated version for each market. Work closely with your manufacturer and a cosmetic regulatory consultant if launching in multiple regions; the cost of compliance ($1,000–$3,000) is far less than the cost of product recalls or regulatory enforcement.
Ingredients in this answer: Hydrolyzed Collagen
Read the full guide on Private Label Peptide Body Butter Manufacturer Low MOQ →